Risk of Virus Contamination Through Surgical Smoke During Minimally Invasive Surgery: A Systematic Review of the Literature on a Neglected Issue Revived in the COVID-19 Pandemic Era



      The coronavirus disease 2019 (COVID-19) pandemic raised concerns about the safety of laparoscopy due to the risk of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) diffusion in surgical smoke. Although no case of SARS-CoV-2 contagion related to surgical smoke has been reported, several international surgical societies recommended caution or even discouraged the use of a laparoscopic approach.


      To evaluate the risk of virus spread due to surgical smoke during surgical procedures.

      Evidence acquisition

      We searched PubMed and Scopus for eligible studies, including clinical and preclinical studies assessing the presence of any virus in the surgical smoke from any surgical procedure or experimental model.

      Evidence synthesis

      We identified 24 studies. No study was found investigating SARS-CoV-2 or any other coronavirus. About other viruses, hepatitis B virus was identified in the surgical smoke collected during different laparoscopic surgeries (colorectal resections, gastrectomies, and hepatic wedge resections). Other clinical studies suggested a consistent risk of transmission for human papillomavirus (HPV) in the surgical treatments of HPV-related disease (mainly genital warts, laryngeal papillomas, or cutaneous lesions). Preclinical studies showed conflicting results, but HPV was shown to have a high risk of transmission.


      Although all the available data come from different viruses, considering that the SARS-CoV-2 virus has been shown in blood and stools, the theoretical risk of virus diffusion through surgical smoke cannot be excluded. Specific clinical studies are needed to understand the effective presence of the virus in the surgical smoke of different surgical procedures and its concentration. Meanwhile, adoption of all the required protective strategies, including preoperative patient nasopharyngeal swab for COVID-19, seems mandatory.

      Patient summary

      In this systematic review, we looked at the risk of virus spread from surgical smoke exposure during surgery. Although no study was found investigating severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) or any other coronavirus, we found that the theoretical risk of virus diffusion through surgical smoke cannot be excluded.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic and Personal
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to European Urology Focus
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


      1. Centers for Disease Control and Prevention. Interim guidance for healthcare facilities: preparing for community transmission of COVID-19 in the United States.

      2. American College of Surgeons. COVID-19: guidance for triage of non-emergent surgical procedures.

      3. Royal College of Surgeons. COVID-19: good practice for surgeons and surgical teams.

      4. Stensland K.D., Morgan T.M., Moinzadeh A., et al. Considerations in the triage of urologic surgeries during the COVID-19 pandemic. Eur Urol. In press.

      5. Ficarra V., Novara G., Abrate A., et al. Urology practice during COVID-19 pandemic. Minerva Urol Nefrol. In press.

      6. Zheng M.H., Boni L., Fingerhut A. Minimally invasive surgery and the novel coronavirus outbreak: lessons learned in China and Italy. Ann Surg. In press.

      7. American College of Surgeons. COVID-19: considerations for optimum surgeon protection before, during, and after operation.

      8. SAGES and EAES. SAGES recommendation regarding surgical response to COVID-19 crisis.

      9. The Royal College of Surgeons of Edinburgh. Updated intercollegiate general surgery guidance on COVID-19.

      10. European Society for Gynaecological Endoscopy. Recommendations on gynaecological laparoscopic surgery during COVID-19 outbreak.

      11. EAU Robotic Urology Section. Guidelines during COVID-19 emergency.

      12. National Toxicology Program/Office of Health Assessment and Translation (NTP/OHAT). Risk of bias rating tool for human and animal studies.

        • Moher D.
        • Liberati A.
        • Tetzlaff J.
        • Altman D.G.
        • PRISMA Group
        Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.
        Ann Intern Med. 2009; 151: 264-269
        • Abramson A.L.
        • DiLorenzo T.P.
        • Steinberg B.M.
        Is papillomavirus detectable in the plume of laser-treated laryngeal papilloma?.
        Arch Otolaryngol Head Neck Surg. 1990; 116: 604-607
        • Andre P.
        • Orth G.
        • Evenou P.
        • Guillaume J.C.
        • Avril M.F.
        Risk of papillomavirus infection in carbon dioxide laser treatment of genital lesions.
        J Am Acad Dermatol. 1990; 22: 131-132
        • Ferenczy A.
        • Bergeron C.
        • Richart R.M.
        Carbon dioxide laser energy disperses human papillomavirus deoxyribonucleic acid onto treatment fields.
        Am J Obstet Gynecol. 1990; 163: 1271-1274
        • Hallmo P.
        • Naess O.
        Laryngeal papillomatosis with human papillomavirus DNA contracted by a laser surgeon.
        Eur Arch Otorhinolaryngol. 1991; 248: 425-427
        • Bergbrant I.M.
        • Samuelsson L.
        • Olofsson S.
        • Jonassen F.
        • Ricksten A.
        Polymerase chain reaction for monitoring human papillomavirus contamination of medical personnel during treatment of genital warts with CO2 laser and electrocoagulation.
        Acta Derm Venereol. 1994; 74: 393-395
        • Gloster Jr, H.M.
        • Roenigk R.K.
        Risk of acquiring human papillomavirus from the plume produced by the carbon dioxide laser in the treatment of warts.
        J Am Acad Dermatol. 1995; 32: 436-441
        • Capizzi P.J.
        • Clay R.P.
        • Battey M.J.
        Microbiologic activity in laser resurfacing plume and debris.
        Lasers Surg Med. 1998; 23: 172-174
        • Hughes P.S.
        • Hughes A.P.
        Absence of human papillomavirus DNA in the plume of erbium:YAG laser–treated warts.
        J Am Acad Dermatol. 1998; 38: 426-428
        • Lobraico R.V.
        • Schifano M.J.
        • Brader K.R.
        A retrospective study on the hazards of the carbon dioxide laser plume.
        J Laser Appl. 1988; 1: 1-8
        • Calero L.
        • Brusis T.
        Laryngeal papillomatosis—first recognition in Germany as an occupational disease in an operating room nurse [article in German].
        Laryngorhinootologie. 2003; 82: 790-793
        • Ilmarinen T.
        • Auvinen E.
        • Hiltunen-Back E.
        • Ranki A.
        • Aaltonen Lm
        • Pitkäranta A.
        Transmission of human papillomavirus DNA from patient to surgical masks, gloves and oral mucosa of medical personnel during treatment of laryngeal papillomas and genital warts.
        Eur Arch Otorhinolaryngol. 2012; 269: 2367-2371
        • Neumann K.
        • Cavalar M.
        • Rody A.
        • Friemert L.
        • Beyer D.A.
        Is surgical plume developing during routine LEEPs contaminated with high-risk HPV? A pilot series of experiments.
        Arch Gynecol Obstet. 2018; 297: 421-424
        • Zhou Q.
        • Hu X.
        • Zhou J.
        • Zhao M.
        • Zhu X.
        • Zhu X.
        Human papillomavirus DNA in surgical smoke during cervical loop electrosurgical excision procedures and its impact on the surgeon.
        Cancer Manage Res. 2019; 11: 3643-3654
        • Kwak H.D.
        • Kim S.H.
        • Seo Y.S.
        • Song K.J.
        Detecting hepatitis B virus in surgical smoke emitted during laparoscopic surgery.
        Occup Environ Med. 2016; 73: 857-863
        • Wisniewski P.M.
        • Warhol M.J.
        • Rando R.F.
        • Sedlacek T.V.
        • Kemp J.E.
        • Fisher J.C.
        Studies on the transmission of viral disease via the CO2 laser plume and ejecta.
        J Reprod Med. 1990; 35: 1117-1123
        • Kunachak S.
        • Sithisarn P.
        • Kulapaditharom B.
        Are laryngeal papilloma virus-infected cells viable in the plume derived from a continuous mode carbon dioxide laser, and are they infectious? A preliminary report on one laser mode.
        J Laryngol Otol. 1996; 110: 1031-1033
        • Dodhia S.
        • Baxter P.C.
        • Ye F.
        • Pitman M.J.
        Investigation of the presence of HPV on KTP laser fibers following KTP laser treatment of papilloma.
        Laryngoscope. 2018; 128: 926-928
        • Best S.R.
        • Esquivel D.
        • Mellinger-Pilgrim R.
        • Roden R.B.S.
        • Pitman M.J.
        Infectivity of murine papillomavirus in the surgical byproducts of treated tail warts.
        Laryngoscope. 2020; 130: 712-717
        • Johnson G.K.
        • Robinson W.S.
        Human immunodeficiency virus-1 (HIV-1) in the vapors of surgical power instruments.
        J Med Virol. 1991; 33: 47-50
        • Hagen K.B.
        • Kettering J.D.
        • Aprecio R.M.
        • Beltran F.
        • Maloney R.K.
        Lack of virus transmission by the excimer laser plume.
        Am J Ophthalmol. 1997; 124: 206-211
        • Taravella M.J.
        • Weinberg A.
        • Blackburn P.
        • May M.
        Do intact viral particles survive excimer laser ablation?.
        Arch Ophthalmol. 1997; 115: 1028-1030
        • Taravella M.J.
        • Weinberg A.
        • May M.
        • Stepp P.
        Live virus survives excimer laser ablation.
        Ophthalmology. 1999; 106: 1498-1499
        • Garden J.M.
        • O’Banion M.K.
        • Shelnitz L.S.
        • et al.
        Papillomavirus in the vapor of carbon dioxide laser-treated verrucae.
        JAMA. 1988; 259: 1199-1202
        • Sawchuk W.S.
        • Weber P.J.
        • Lowy D.R.
        • Dzubow L.M.
        Infectious papillomavirus in the vapor of warts treated with carbon dioxide laser or electrocoagulation: detection and protection.
        J Am Acad Dermatol. 1989; 21: 41-49
      13. Chang L., Yan Y., Wang L. Coronavirus disease 2019: coronaviruses and blood safety. Transfus Med Rev. In press.

        • Zhang W.
        • Du RH Li B.
        • et al.
        Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes.
        Emerg Microbes Infect. 2020; 9: 386-389
      14. Simonato A., Giannarini G., Abrate A., et al. Pathways for urology patients during the COVID-19 pandemic. Minerva Urol Nefrol. In press.

        • Li C.I.
        • Pai J.Y.
        • Chen C.H.
        Characterization of smoke generated during the use of surgical knife in laparotomy surgeries.
        J Air Waste Manag Assoc. 2020; 70: 324-332
        • Limchantra I.V.
        • Fong Y.
        • Melstrom K.A.
        Surgical smoke exposure in operating room personnel: a review.
        JAMA Surg. 2019; 154: 960-967